Story
Jones Lang LaSalle Stock Climbs on Q2 Earnings Beat and Raised Outlook
Summary
The commercial real estate services firm surpassed analyst estimates for second-quarter profit and revenue, and boosted its full-year earnings guidance, citing strong advisory activity.
Shares of Jones Lang LaSalle (NYSE: JLL) gained in early trading after the commercial real estate services company reported second-quarter 2026 financial results that exceeded analyst expectations and raised its full-year profit forecast.
Strong Q2 Performance
JLL announced before the market opened that it generated $6.9 billion in revenue for the quarter, an 11% increase from the same period last year. This figure surpassed the consensus analyst forecast of $6.74 billion, according to Investing.com.
On the bottom line, the company posted adjusted earnings per share (EPS) of $5.26. This result was significantly ahead of the $4.52 per share anticipated by analysts.
Upgraded Guidance and Capital Returns
Citing continued momentum, JLL's management raised its full-year adjusted EPS guidance. The new forecast projects approximately 34% year-over-year growth at the midpoint, signaling strong confidence for the second half of the year.
AdThe company attributed the record quarterly performance to a surge in its advisory business, where revenues climbed 21% in local currency. Growth was led by accelerating demand in office, industrial, and data center leasing. CEO Christian Ulbrich credited the results to the company’s "compelling value proposition and growing demand for core services." JLL also returned capital to shareholders, repurchasing $110 million in shares during the quarter, bringing the total for the first half of 2026 to $410 million.
Broader Industry Strength
The positive results from JLL arrive amid signs of a wider recovery in the commercial real estate services sector. Industry peer CBRE Group also recently reported strong Q2 2026 results, with revenues rising approximately 15.5% year-over-year. This suggests a broad-based improvement in leasing and capital markets activity.
A constructive macroeconomic backdrop, with major U.S. equity indices trading higher, also provided a tailwind for the stock. Following the report, JLL shares were trading around $345, approaching their 52-week high of $363.06.
Read next
More on Stocks
ClearPoint Neuro Stock Plummets 24% on uniQure's Huntington's Trial Setback
Shares of ClearPoint Neuro fell sharply after its partner, uniQure, announced that its experimental gene therapy for Huntington's disease failed to meet its primary goal in a clinical trial, raising concerns about future revenue for ClearPoint's delivery technology.
Webull to Launch No-Code AI Tool for Trade Preparation via Claude, Perplexity
The online brokerage is expanding its cloud-based AI integration, allowing eligible U.S. users to research markets and prepare trades using natural language on platforms like Claude and Perplexity, without any software installation.
Iovance Biotherapeutics Raises Revenue Forecast on Strong Amtagvi Demand, Shares Surge
The biotech company boosted its full-year 2026 revenue guidance by approximately 15% at the midpoint, citing accelerating demand for its cancer therapies Amtagvi and Proleukin.
J.P. Morgan Upgrades Bureau Veritas to Overweight on Growth and M&A Outlook
J.P. Morgan raised its rating on the inspection and certification firm to “Overweight,” citing an expected recovery in organic growth driven by data centers and an increased capacity for acquisitions.